Teva, Sun Pharma Shipments Surge as Cartel Case Looms — Panjiva
Más

Supply Chain Research

Teva, Sun Pharma Shipments Surge as Cartel Case Looms

European Union 823 Health Care 352 India 509 U.S. 5314

Teva and Sun Pharmaceuticals have been in discussions with the U.S. Department of Justice to settle a price-fixing probe into generic pharmaceutical pricing. The stakes are high given convictions could prevent firms from working with Medicare / Medicaid according to Bloomberg. U.S. seaborne imports associated with Teva climbed 29.9% year over year in October after a 13.3% rise in 3Q, potentially indicating expectations of business-as-usual. Teva has a diverse sourcing base while 83.9% of shipments linked to Sun Pharma were sourced from India. Sun Pharma’s shipments have also surged. Ther...

Copyright © 2024 Panjiva Supply Chain Intelligence, a product offering from S&P Global Market Intelligence Inc. All rights reserved.